RNAZ (TransCode Therapeutics) Yalpi foyda marjasi

RNAZ (TransCode Therapeutics) - kompaniyaning tovar belgisi

TransCode Therapeutics (RNAZ) institutlar bilan sinergiya va biolaboratoriyalarni sotib olish orqali RNKga asoslangan dori vositalarini ishlab chiqmoqda. FDA testlarining yuqori xarajatlari va patent himoyasi bozorga kirish uchun sezilarli to'siqni yaratadi. Maqsadli yalpi foyda ko'rsatkichi ishlab chiqarish samaradorligini namoyish etadi, bunda 0.00 darajasi joriy miqdorni aks ettiradi. Molekulalarni o'smalarga yetkazib berishga oid intellektual kapital litsenziyalash shartnomalari orqali kelgusidagi monetizatsiyani ta'minlaydi.

RNAZ (TransCode Therapeutics, Inc.) Yalpi marja tarixi 04.07.2022dan 19.11.2026gacha

transcodetherapeutics.com (RNAZ) moliyaviy va bozor koʻrsatkichlari kesimi

Kompaniyaning jamlanma tahlili:TransCode Therapeutics
TransCode Therapeutics tovar namunasi

TransCode Therapeutics kompaniyasining klinik sinovlar uchun sarflayotgan katta xarajatlari bevosita xarajatlar nazoratini hayotiy muhim omilga aylantiradi. Valovoy marjaning tahlili umumiy daromaddan sotilgan tovarlar tannarxini ayirish orqali RNA terapiyasini yetkazib berish patentlarining monetizatsiya samaradorligini baholash imkonini beradi. Ushbu grafikdagi barqaror tendentsiya kompaniyaning intellektual ustunligi kapitalni inflyatsiyadan himoya qilish uchun yetarli pul oqimini yaratish qobiliyatini tasdiqlaydi.

Muhim raqobatchilar

Yalpi foyda bo'yicha rentabellik Tempus AI Inc|QGEN (Qiagen NV) - Yalpi marja|Yalpi foyda bo'yicha rentabellik Ionis Pharma (IONS)|Yalpi rentabellik Repligen Corp (RGEN)|RNA - Yalpi foyda marjasi|crisprtx.com - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi WGS|RARE - Yalpi rentabellik|Beam Tx (BEAM) - Yalpi foyda bo'yicha rentabellik|SRPT (Sarepta Therapeutics Inc) - Yalpi foyda bo'yicha rentabellik|TWST: Yalpi foyda koeffitsiyenti|TXG (10xgenomics.com) - Yalpi marja|NTLA (Intellia Therapeutics, Inc.) - Yalpi foyda koeffitsiyenti|Yalpi rentabellik Stoke Corp (STOK)|Yalpi foyda bo'yicha sotuv rentabelligi BioLife|Yalpi marja WVE (Wave Life Sciences Ltd)|MAZE: Sotuvning yalpi rentabelligi|Sionna Therapeutics, Inc. - Yalpi marja|Yalpi foyda normasi PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Yalpi foyda bo'yicha rentabellik|QURE - Yalpi foyda bo'yicha sotuv rentabelligi|MGTX (MeiraGTx Corp) - Yalpi marja|Yalpi foyda marjasi REGENXBIO Inc. RGNX|Yalpi rentabellik Solid Biosciences (SLDB)|Ocugen Corp - Sotuvning yalpi rentabelligi|Yalpi rentabellik Pacific Biosciences PACB|Yalpi foyda koeffitsiyenti BNTC (Benitec)|Design Corp - Yalpi marja|Rocket Pharmaceuticals - Yalpi foyda koeffitsiyenti|Sotuvning yalpi rentabelligi 4D Molecular Therapeutics, Inc.|Yalpi foyda marjasi Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Yalpi marja|Yalpi foyda marjasi Editas EDIT|Yalpi marja SLN|ProQR Therapeutics - Sotuvning yalpi rentabelligi|Yalpi marja CDXS (Codexis, Inc.)|SGMO: Sotuvning yalpi rentabelligi|Nautilus Biotechnology - Yalpi marja|Yalpi foyda normasi MGX (Metagenomi, Inc)|DTIL: Yalpi marja|GBIO: Yalpi foyda koeffitsiyenti|Yalpi rentabellik Boundless Bio Inc.|Yalpi foyda bo'yicha rentabellik Exicure (XCUR)|Yalpi marja IMNN|PHIO (Phio Pharmaceuticals Corp.) - Yalpi foyda normasi|Mustang Bio, Inc. - Yalpi foyda bo'yicha rentabellik|bionanogenomics.com (BNGO) - Yalpi foyda marjasi|Applied DNA - Yalpi marja|Yalpi foyda marjasi Bluebird Bio|ImmunoPrecise (IPA) - Yalpi rentabellik|Yalpi foyda bo'yicha marjinallik OMGA (Omega)|Yalpi rentabellik Singular Genomics Systems|Yalpi foyda marjasi regulusrx.com RGLS|Yalpi rentabellik Syros Pharmaceuticals Inc. (SYRS)|Yalpi foyda bo'yicha sotuv rentabelligi Codex DNA|Yalpi rentabellik TRACON TCON|Unity Biotechnology, Inc - Yalpi rentabellik